Neuro-ophthalmology Nuggets: Publications

Index

Lars Frisén: list of publications 1963 - 2017

Monographs

Ophthimus System Manual, eds. 1, 2, and 3. HighTech Vision, Malmö and Göteborg, 1987, 1990, 1994.
Frisén L: Clinical Tests of Vision. Raven Press, New York, 1990, pp 212.
Neuro-ophthalmology Nuggets. www.neuro-o.se/

Patents

Frisén L. Biomicroscopic eye contact glass. United States Patent No. 3,820,879, 1974 (cf #19 below)
Frisén L. Device and method for a vision test. EU Patent No. EP1 872 712 B1, 2009 (cf #148 below)
Frisén L. Device and method for a vision test. United States Patent No. 806 183 9 B2, 2011 (cf #148 below)

Scientific papers (latest first)

161. Frisén L. Swelling of the optic nerve head: a backstage view of a staging scheme. J Neuro-Ophthalmol 37: 3-6, 2017.
160. Frisén L. Dichoptic reaction times open a new window on functional loss of vision. Ophthalmology 123:1834-5, 2016.
159. Johnson CA, Wall M, Frisén L, Wagschal T. Development and reliability of the tangent corner test (TCT) in visual field evaluation. Invest Ophthalmol Vis Sci 57: 5977, 2016.
158. Winther C, Frisén L. Self-testing of vision in age-related macula degeneration: a longitudinal pilot study using a smartphone-based rarebit test. J Ophthalmol, vol. 2015, Article ID 285463, 2015 (free access).
157. Winther C, Frisén L. New rarebit vision test captures macular deficits hidden to acuity tests. Acta Ophthalmol 93:481-485, 2015
156. Frisén L. Identification of functional visual field loss by automated static perimetry. Acta Ophthalmol 92: 805-809, 2014.
155. Frisén L. Rapid assessment of neuro-visual integrity using multiple rarebits. Ophthalmology 120:1756-1760, 2013
154. Frisén L. Performance of a rapid rarebit central-vision test with optic neuropathies. Optom Vis Sci 89: 1192–1195, 2012.
153. Frisén L. Ocular torsions and the subjective visual vertical with central vestibulo-ocular system lesions: independence disproved. Acta Neurol Scand 126: 205-9, 2012.
152. Kardon RH, Scott CJ, Lee AG, Frisén L. Wall M. Optical coherence tomography for optic disc edema. Arch Ophthalmol 129: 1246-7, 2011.
151. Blomsterwall E, Frisén L, Wikkelsö C. Postural function and subjective eye level in patients with idiopathic normal pressure hydrocephalus. J Neurol 258: 1341-6, 2011.
150. Frisén L. Deviations of the visual upright in 3D in disorders of the brainstem. A clinical exploration. Brain 133:3541-3551, 2010.
149. Scott CJ, Kardon RH, Lee AG, Frisén L, Wall M. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography (OCT) compared to clinical expert assessment using a clinical staging scale. Arch Ophthalmol 128:705-711, 2010.
148. Winther C, Frisén L. A compact rarebit test for macular disease. Br J Ophthalmol 94:324-327, 2010.
147. Frisén L. Scope of super-resolution in central vision. Br J Ophthalmol 94:97-100, 2010.
146. Frisén L. The Amsler grid in modern clothes. Br J Ophthalmol 93:714-716, 2009.
145. Frisén L, Jensen C. How robust is the chiasm? Perimetric and neuro-imaging correlations. Acta Neurol Scand 117, 198-204, 2008.
144. Frisén L: Evolution of drusen of the optic nerve head over 23 years. Report of a case. Acta Ophthalmol Scand, 86: 111-112, 2008.
143. Frisén L: Anisotropic enhancement of the retinal nerve fiber layer. Neuro-Ophthalmology 31:99 – 103, 2007.
142. Frisén L: The lazy shadow – a monocular counterpart to the Pulfrich stereo phenomenon. Br J Ophthalmol 91;1296-1298, 2007.
141. Rudolph T, Frisén L: Effect of ageing on visual field defects due to stable lesions. Br J Ophthalmol 91;1276-1278, 2007.
140. Frisén L: Rarebit perimetrisi. In: Görme Alani El Kitabi, Ed. Aydin P. Aksu Basim Yayin Dagitim, Istanbul 2005; 61 – 64 (in Turkish).
139. Nilsson D, Malmgren K, Rydenhag B, Frisén L: Visual field defects after temporal lobectomy - comparing methods and analysing resection size. Acta Neurol Scand 110:301-7, 2004.
138. Wall M, Chauhan C, Frisén L, House PH: The visual field of high-pass resolution perimetry in normal subjects. J Glaucoma 13:15-21, 2004.
137. Frisén L: Vigabatrin-associated loss of vision: rarebit perimetry illuminates dose-damage relationship. Acta Ophthalmol Scand 82: 54-8, 2004.
136. Frisén L, Malmgren K: Characterization of vigabatrin-associated optic atrophy. Acta Ophthalmol Scand 81: 466 – 73, 2003.
135. Haghighi S, Frisén L, Odén A, Anderson O: Multiple sclerosis trait: sensitive vision testing defines group without any indication of neuronal damage. Acta Neurol Scand 108:319-22, 2003
134. Frisén L: Spatial vision in visually asymptomatic subjects at high risk for multiple sclerosis. J Neurol Neurosurg Psychiat 74:1145-7, 2003
133. Wikkelsö C, Blomsterwall E, Frisén, L: Subjective visual vertical and Romberg’s test correlations in hydrocephalus. J Neurol 250:741-5, 2003
132. Rodriguez-Catarino M, Frisén L, Wikholm G, Elfverson J, Svendsen P, Quiding L, Svendsen P: Intracranial carotid artery aneurysms and cranial nerve dysfunction: roles of deformation and pulsation. Neuroradiology 45: 236 – 240, 2003.
131. Frisén L: Closing perimetry’s sensitivity gap: a rarebit approach. In: Perimetry Update 2002/2003, D Henson and M Wall, eds. Kugler, The Hague 2004, pp 213 – 219.
130. Frisén L: New, sensitive window on abnormal spatial vision: rarebit probing. Vision Res 42:1931-9, 2002.
129. Svendsen PA, Wikholm G, Rodriguez M, Enoksson P, Frisén L, Strömland K, Seregard S: Orbital lymphatic malformations. Direct puncture and sclerotherapy with Sotradecol. Intervent Neuroradiol 7: 193 – 199, 2001.
128. Lycke J, Tollesson PO, Frisén L: Asymptomatic visual loss in multiple sclerosis. J Neurol 248: 1079 – 86, 2001.
127. Malmgren K, Ben-Menachem E, Frisén L: Vigabatrin visual toxicity: evolution and dose dependence. Epilepsia. 42: 609-15, 2001.
126. Frisén L: Student's visual field map. In: Perimetry Update 2000/2001, M Wall and RP Mills, eds. Kugler, The Hague, 2001, pp 81 - 84.
125. Lindberger M, Alenius M, Frisén L, Johannessen SI, Larsson S, Malmgren K, Tomson T: Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabantin in Refractory Epilepsy Add-on Treatment. Epilepsia 10: 1289 - 95, 2000.
124. Frisén L: Perspectives on neuro-ophthalmological visual fields. In: Principles and Practice of Ophthalmology, Ed DM Albert and FA Jakobiec. 2nd ed, Volume 5, Chapter 281. Saunders, Philadelphia, 2000.
123. Frisén L: Practical estimation of ocular torsion and the subjective vertical. Neuro-ophthalmology 23: 195, 2000.
122. Frisén L: Estimating cataract by means of resolution perimetry. In: Perimetry Update 1998/99, M Wall and JM Wild, eds. Kugler, Amsterdam 1999, pp 289 - 299.
121. Frisén L, von Essen E, Roos A: Surgically created fourth-third cranial nerve communication: temporary success in a child with bilateral third nerve hamartomas. Case report. J Neurosurg 90:542 - 545, 1999.
120. Frisén L: Reconsideration of visual field incongruence. In: Perimetry Update 1996/97, M Wall and A Heijl, eds. Kugler, Amsterdam 1997, pp 365 - 376.
119. Frisén L: La périmétrie passe-haute. In: Bechetoille A: Les Glaucomes, Vol 1, pp 126 - 129. Japperenard, Angers 1997 (in French).
118. Frisén L, Rossitti S: Relative dispersion analysis improves perimetric sensitivity. Vision Res 36: 491 - 497, 1996.
117. Frisén L: Clinical vision testing: A survival guide. Neuro-Ophthalmology 14: S12, 1994.
116. Rossitti S, Frisén L: Remodelling of the retinal arterioles in descending optic atrophy follows the principle of minimum work. Acta Physiol Scand 152: 333 - 340, 1994.
115. Frisén L: Vasospastisk amaurosis fugax: finns sådana djur? Läkartidningen 91: 1595-1596, 1994 (in Swedish).
114. Frisén L: Névrite optique: diagnostics positif et différentiel. Réalités Ophtalmol 10: 7 - 12, 1993 (in French).
113. Frisén L: High-pass resolution perimetry: central-field neuroretinal correlates. Vision Res 35: 293 - 301, 1995.
112. Lycke J, Svennerholm B, Hjelmqvist E, Frisén L, Badr G, Andersson M, Vahlne A, Andersen O: Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study. J Neurol 243: 214 - 224, 1996.
111. Frisén L: High-pass resolution perimetry. A clinical review. Doc Ophthalmol 83: 1 - 25, 1993.
110. Frisén L: Ringperimetrie. In: Perimetrie mit besonderer Berücksichtigung der automatischen Perimetrie, Gloor B, ed, Enke, Stuttgart 1993, pp 138 - 149 (in German).
109. Frisén L: Resolution theory and high-pass resolution perimetry (HRP). In: Perimetry Update 1992/93, Mills RP, ed, Kugler, Amsterdam 1993, pp 419 - 427.
108. Frisén L, Nikolajeff F: Properties of high-pass resolution perimetry targets. Acta Ophthalmol 71, 320 - 326, 1993.
107. Frisén L: High-pass resolution perimetry: evidence for parvocellular neural channel dependence. Neuro-ophthalmology 12: 257 - 264, 1992.
106. Frisén L: Theoretical aspects of high-pass resolution perimetry. HighTech Vision, Malmö, 1991.
105. Frisén L: High-pass resolution perimetry and age-related loss of visual pathway neurons. Acta Ophthalmol 69: 511 - 515, 1991.
104. Frisén L: A child's play version of high-pass resolution perimetry. In: Perimetry Update 1990/91, Mills RP and Heijl A, eds, Kugler, Amsterdam 1991, p 349.
103. Frisén L: Graphic visual field difference plots. In: Perimetry Update 1990/91, Mills RP and Heijl A, eds, Kugler, Amsterdam 1991, pp 359 - 363.
102. Frisén L, Lindblom B: A primer of ophthalmic computer graphics. Doc Ophthalmol 74: 337- 350, 1990.
101. Petruson B, Frisén L: Decompression of the orbit using a lateral rhinotomy appraoch in patients with malignant endocrine exophthalmos. Clin Otolaryngol 15: 181 - 184, 1990.
100. Frisén L: High-pass resolution perimetry: recent developments. Perimetry Update 1988/89. A Heijl, ed. Kugler & Ghedini, Amsterdam 1989, pp 369 - 375.
99. Frisén L, Lindblom B: Binocular summation in humans: evidence for a hierarchic model. J Physiol, 402: 773 - 782, 1988.
97. Frisén L: Acuity perimetry: estimation of neural channels. Int Ophthalmol 12: 169 - 174, 1988.
96. Frisén L: Perimetric variability: importance of criterion level. Doc Ophthalmol 70: 323 - 330, 1989.
95. Frisén L: A shape statistic for visual field evaluation. Utility in minor optic neuropathy. Neuro- ophthalmology 9:347 - 354, 1989.
94. Frisén L: High-pass resolution targets in peripheral vision. Ophthalmology 94: 1104 - 1108, 1987.
93. Frisén L: Automatic perimetry: possibilities for feedback and adaptation. Doc Ophthalmol 69: 3 - 9, 1988.
92. Frisén L: A computer-graphics visual field screener using high-pass spatial frequency resolution targets and multiple feedback devices. Doc Ophthalmol Proc Series 49: 441 - 446, 1987.
91. Frisén L: Visual acuity and visual field tests: psychophysical vs pathophysical objectives. In: Physiological Aspects of Clinical Neuro-Ophthalmology, C Kennard and FC Rose, eds. Chapman and Hall, London, 1988, pp 3 - 26.
90. Kjällman L, Frisén L: The cerebral ocular pursuit pathways. A clinico-radiological study of small-field optokinetic nystagmus. J Clin Neuro-Ophthalmol 6: 209 - 214, 1986.
89. Lindblom B, Wikholm M, Frisén L: Sahlgren's Saturation Test for acquired dyschromatopsia: increased lightness enhances sensitivity. Graefe's Arch Clin Exp Ophthalmol 226: 447 - 448, 1988.
88. Svendsen P, Wikholm G, Löfgren J, Frisén L: Embolisering med avlösbar ballong lämpligaste behandlingen av direkt carotis-cavernosusfistel. Läkartidningen 89: 2431 - 33, 1992 (in Swedish).
87. Hanner P, Andersen O, Frisén L, Rosenhall U, Edström S: Clinical observations of effects on central nervous system in patients with acute facial palsy. Arch Otolaryngol Head Neck Surg 113: 516 - 520, 1987.
86. Frisén L: Vanishing optotypes. A new type of acuity test letters. Arch Ophthalmol 104: 1194-1198, 1986.
85. Frisén L, Wikkelsö C: Posttraumatic see-saw nystagmus abolished by ethanol ingestion. Neurology 36: 841-844, 1986.
84. Frisén L: A nystagmus lazy dog. Chapter 24 in Neuro- Ophthalmology Now (Smith JL, Ed), Field, Rich, New York, 1986.
83. Frisén L, Claesson M: Narrowing of retinal arterioles in descending optic atrophy. Ophthalmology 91: 1342-1346, 1984.
82. Frisén L, Quigley HA: Visual acuity in optic atrophy. A quantitative clinicopathological study. Graefe's Arch Clin Exp Ophthalmol 222: 71-74, 1984.
81. Frisén L: Cartographic deformations in orthogonal perimetric maps. Doc Ophthalmol Proc Ser 42: 113-118, 1985.
80. Frisén L: The earliest visual field defects in midchiasmal compression. Doc Ophthalmol Proc Ser 42: 191- 195, 1985.
79. Frisén L, Blomstrand C: Episodic astigmatism heralding generalized myopathy. Ophthalmology 91: 179-182, 1984.
78. Frisén L: Clinical features of optic neuritis: standard examination techniques. Bull Soc Belg Ophtal 208-I:131- 142, 1983.
77. Frisén L: Demyelinating optic neuropathy. Notes on clinical examination techniques. Bull Soc Belg Ophtal 208-I: 359-364, 1983.
76. Frisén L: Fundus changes in acute malnutritional optic neuropathy. Arch Ophthalmol 101: 577-579, 1983.
75. Frisén L: Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiat 45: 13-18, 1982.
74. Frisén L, Kalm H: Sahlgren's Saturation Test for detecting and grading acquired dyschromatopsia. Am J Ophthalmol 92: 252-258, 1981.
73. Frisén L, Frisén M: How good is normal visual acuity? A study of letter acuity thresholds as a function of age. Albrecht von Graefes Arch Klin Exp Ophthalmol 215: 149- 157, 1981.
72. Frisén L: The neurology of visual acuity. Brain 103: 639- 670, 1980.
71. Frisén L: Pupill-lathund. Läkartidningen 78: 575-578, 1981 (in Swedish).
70. Frisén L: Photography of the retinal nerve fibre layer: an optimized procedure. Br J Ophthalmol 64: 641-650, 1980.
69. Frisén L: Ophthalmoscopic evaluation of the retinal nerve fiber layer in neuro-ophthalmologic conditions. In Neuro-Ophthalmology: Focus 1980 (J L Smith, ed.) Masson. pp 53- 67, 1979.
68. Frisén L: Quadruple sectoranopia and sectorial optic atrophy: a distal anterior choroidal syndrome. J Neurol Neurosurg Psychiat 42: 590-594, 1979.
67. Frisén L, Kjällman L, Lindberg B, Svendsen P: Detection of extracranial carotid stenosis by computed tomography. Lancet 1: 1319-1320, 1979.
66. Frisén L: Visual field defects due to hypoplasia of the optic nerve. Doc Ophthalmol Proc Ser 19: 81-86, 1979.
65. Frisén L, Kjällman L, Svendsen P: Computed frontal tomography (CFT) of the orbit using the EMI CT 1010 Head Scanner. Neuroradiology 15: 263-265, 1978.
64. Frisén L: High magnification direct ophthalmoscopy. Am J Ophthalmol 86: 272-273, 1978.
63. Frisén L, Frisén M: Micropsia and visual acuity in macular edema. A study of the neuroretinal basis of visual acuity. Albrecht von Graefes Arch Klin Exp Ophthalmol 210: 69-77, 1979.
62. Frisén L: Nystagmus-lathund. Läkartidningen 78: 2229- 2232, 1981 (in Swedish).
61. Frisén L: Lateropulsion of the eyes. A localizing brain stem sign. J Neurol 218: 171-177, 1978.
60. Frisén L: Simple visual field tests: the tangent screen. In: Topics in Neuro-ophthalmology, ed. by H S Thompson, R Daroff, L Frisén, J S Glaser and M D Sanders. Williams & Wilkins, pp 67-70, 1979.
59. Frisén L: Kinetic perimetry: techniques and strategies. In: Topics in Neuro-ophthalmology ed. by H S Thompson, R Daroff, L Frisén, J S Glaser and M D Sanders. Williams & Wilkins, pp 20-29, 1979.
58. Frisén L: Cornerstones of perimetric strategy. In: Topics in Neuro-ophthalmology, ed. by H S Thompson, R Daroff, L Frisén, J S Glaser and M D Sanders. Williams & Wilkins, pp 3-19, 1979.
57. Frisén L, Löfgren J: Communicating exophthalmos: a sign of bilateral orbital roof defects. Acta Neurochir 41: 157-161, 1978.
56. Frisén L: Akveduktsyndromet. Läkartidningen 74: 3089- 3091, 1977 (in Swedish).
55. Frisén L, Schöldström G, Svendsen P: Drusen of the optic nervehead. Verification by computerized axial tomography. Arch Ophthalmol 96: 1611-1614, 1978.
54. Frisén L: Papillödem vid högt intrakraniellt tryck. Läkartidningen 74: 2758, 1977 (in Swedish).
53. Frisén L, Sjöstrand J: Contrast sensitivity in optic neuritis. A preliminary report. Doc Ophthalmol Proc Ser 17: 165-174, 1979.
52. Sjöstrand J, Frisén L: Contrast sensitivity in macular disease. A preliminary report . Acta Ophthalmol 55: 507- 514, 1977.
51. Frisén L, Schöldström G: Relationship between perimetric eccentricity and retinal locus in a human eye. Comparison with theoretical calculations. Acta Ophthalmol 55: 63-68, 1977.
50. Frisén L, Frisén M: A simple relationship between the probability distribution of visual acuity and the density of retinal output channels. Acta Ophthalmol 54: 437-444, 1976.
49. Frisén L, Holmegaard L, Rosencrantz M: Sectorial optic atrophy and homonymous, horizontal sectoranopia: a lateral choroidal artery syndrome? J Neurol Neurosurg Psychiat 41: 374-380, 1978.
48. Frisén L, Holm M: Visual field defects associated with choroidal folds. In: Neuro-ophthalmology, Vol. IX, ed. by J S Glaser. Mosby, Saint Louis 1977.
47. Frisén L, Holm M: Visual field defects associated with chorioretinal folds. Doc Ophthalmol Proc Ser 14: 327-330, 1977.
46. Frisén L, Lindgren S, MacGregor B J L, Stattin S: Sarcoid-like disorder of the intracranial optic nerve. J Neurol Neurosurg Psychiat 40: 702-707, 1977.
45. Frisén L, Sjöstrand J, Norrsell K, Lindgren S: Cyclic compression of the intracranial optic nerve: patterns of visual failure and recovery. J Neurol Neurosurg Psychiat 39: 1109-1113, 1976.
44. Frisén L, Holmegaard L: Spectrum of optic nerve hypoplasia. Brit J Ophthalmol 62: 15,1978.
43. Frisén L: Funduscopic correlates of visual field defects in lesions of the anterior visual pathway. Doc Ophthalmol Proc Ser 19: 5-6, 1979.
42. Lundström M, Frisén L: Atrophy of optic nerve fibres in compression of the chiasm. Prognostic implications. Acta Ophthalmol 55: 208-216, 1977.
41. Lundström M, Frisén L: Atrophy of optic nerve fibres in compression of the chiasm. Degree and distribution of ophthalmoscopic changes. Acta Ophthalmol 54: 623-640, 1976.
40. Lundström M, Frisén L: Evolution of descending optic atrophy. A case report. Acta Ophthalmol 53: 738-746, 1975.
39. Frisén L: Facial paralysis: experience with an elastic eyelid cerclage. Acta Ophthalmol 54: 382, 1976.
38. Hoyt W F, Frisén L: Supranuclear ocular motor control. Some clinical considerations - 1974. In: Basic Mechanisms of Ocular Motility and their Clinical Implications, ed. by G Lennerstrand & P Bach-y-Rita. Pergamon Press, Oxford 1975.
37 Frisén L: Informal testing of color saturation in the visual field: clinical experience. Ann Ther Clin Ophtalmol 25: 289-292, 1974.
36. Frisén L: What's wrong with kinetic perimetry? Ann Ther Clin Ophtalmol 25: 174-178, 1974.
35. Frisén L, Glansholm A: Optical and neural resolution in peripheral vision. Invest Ophthalmol. 14: 528-536, 1975.
34. Frisén L: An ideal test object for the tangent screen. Acta Ophthalmol 52: 373-377, 1974.
33. Frisén L, Frisén M: Objective recognition of abnormal isopters. Acta Ophthalmol 53: 378-392, 1975.
32. Frisén L: Amaurosis fugax - differentialdiagnostik och terapi. Läkartidningen 71: 2800-2802, 1974 (in Swedish).
31. Frisén L, Hoyt W F, Bird A C, Weale R A: Diagnostic uses of the Pulfrich phenomenon. Lancet 1: 385-386, 1973.
30. Frisén L, Hoyt W F: Insidious atrophy of retinal nerve fibers in multiple sclerosis. Funduscopic identification in patients with and without visual complaints. Arch Ophthalmol 92: 91-97, 1974.
29. Hoyt W F, Frisén L, Newman N M: Funduscopy of nerve fiber layer defects in glaucoma. Invest Ophthalmol 12: 814-829, 1973.
28. Frisén L: Resolution at low contrast with a fundus camera. Comparison of various photographic films. Invest Ophthalmol 12: 865-869, 1973.
27. Frisén L, Hoyt W F: Unsharp masking in fundus photography. Invest Ophthalmol 12: 461-464, 1973.
26. Frisén L, Hoyt W F, Tengroth B: Optociliary veins, disc pallor and visual loss. A triad of signs indicating spheno-orbital meningioma. Acta Ophthalmol 51: 241-249, 1973.
25. Frisén L: Optokinetisk nystagmus i neurologisk fokaldiagnostik. Läkartidningen 70: 1306-1308, 1973 (in Swedish).
24. Frisén L, Hedin A: Illumination box for colour vision test. Acta Ophthalmol 50: 520-524, 1972.
23. Frisén L: Forced motion attachment for the Goldmann perimeter. Ophthalmologica 165: 482-488, 1972.
22. Frisén L: A versatile color confrontation test for the central visual field. A comparison with quantitative perimetry. Arch Ophthalmol 89: 3-9, 1973.
21. Frisén L: Exophthalmos: measuring problems. Acta Ophthalmol 50: 627, 1972.
20. Frisén L: Genuine relative, binasal hemianopia. Report of a case. Acta Ophthalmol 49: 734-740, 1971.
19. Frisén L: An adjustable biomicroscopy contact glass with erect imagery. Arch Ophthalmol 87: 202-205, 1972.
18. Frisén L: On objective analysis in kinetic perimetry. Acta Ophthalmol 48: 1195-1206, 1970.
17. Frisén L: Ögonmottagning i långtidsvård. Sjukhuset 47: 474-477, 1970 (in Swedish).
16. Frisén L, Jerndal T: Rehabilitering av synhandikappade. Pehr Dubb Journalen 4: 42-45, 1970 (in Swedish).
15. Frisén L: The cartographic deformations of the visual field. Ophthalmologica 161: 38-54, 1970.
14. Frisén L: Integral arc illumination for projection perimeters. Acta Ophthalmol 47: 1176-1180, 1969.
13. Frisén L, Prame G: Effects of hypophysectomy and thyroxine on volume and biochemistry of orbital tissue in the crucian carp (Carassius carassius L.). Exp Eye Res 7: 342-353, 1968.
12. Frisén L: Methodological studies on experimental exophthalmos. PhD Thesis, University of Gothenburg 1968, pp 47.
11. Frisén L: Simultaneous bioassay of exophthalmogenic and thyrotrophic substances. II. The TSH assays. Acta Endocrinol 58: 157-171, 1968.
10. Frisén L: Simultaneous bioassay of exophthalmogenic and thyrotrophic substances. I. The EPS assay. Acta Endocrinol 58: 142-156, 1968.
9. Frisén L: Utvidgad exoftalmometri - från fisk till människa. Nord Med 79: 192, 1968 (in Swedish).
8. Frisén L: Critical analysis of exophthalmometry. An experimental evaluation of conventional and extended methods. Acta Ophthalmol 45: 631-649, 1967.
7. Frisén L, Frisén M: Analysis of the topographic distribution of thyroid activity in a teleost fish: Carassius carassius L. Acta Endocrinol 56: 533-546, 1967.
6. Frisén L: Rapid transmandibular hypophysectomy of small fish. Experientia 23: 1079, 1967.
5. Frisén L: Reliability of intraperitoneal injections in fish. Experientia 23: 883, 1967.
4. Tengroth B, Frisén L: Endocrine exophthalmos. In G. Asboe-Hansen (ed.): Hormonal control of connective tissue. Munksgaard, Copenhagen 1966, pp 193-222.
3. Frisén L, Tengroth B: On the occurrence and nature of exophthalmogenic substances, especially in human serum. Acta Ophthalmol 43: 496-513, 1965.
2. Tengroth B, Brunish R, Frisén L: An improved method for the assay of exophthalmos-producing substance. Acta Ophthalmol 42: 875-880, 1964.
1. Bengmark S, Frisén L, Helander E: A cytotoxic factor in heart disease, especially myocarditis. Acta Allergol 18:479-488, 1963.

Top

End